The role of sentinel lymph node biopsy for melanoma: Evidence assessment

Journal of the American Academy of Dermatology

Volumn 54, Issue 1, 2006, Pages 19-27

  Johnson, Timothy M ^a,c   Sondak, Vernon K ^b   Bichakjian, Christopher K ^a   Sabel, Michael S ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; BIOCHEMISTRY; CORRELATION ANALYSIS; DERMATOLOGY; DISEASE CONTROL; IMMUNOHISTOCHEMISTRY; INTERNET; MEDICAL ASSESSMENT; MEDICAL LITERATURE; MEDICAL RESEARCH; MELANOMA; METASTASIS; MORBIDITY; OUTCOME ASSESSMENT; PATHOLOGY; PREDICTION; PRIORITY JOURNAL; REVIEW; SENTINEL LYMPH NODE BIOPSY; SURVIVAL;

HUMANS; MELANOMA; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 29244472006     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2005.09.029     Document Type: Review

References (109)

1. T.M. Johnson, C.R. Bradford, S.B. Gruber, V.K. Sondak, and J.L. Schwartz Staging workup, sentinel node biopsy, and follow-up tests for melanoma: update of current concepts Arch Dermatol 140 2004 107 113
2. D.L. Morton, and A.J. Cochran The case for lymphatic mapping and sentinel lymphadenectomy in the management of primary melanoma Br J Dermatol 151 2004 308 319
3. N. Medalie, and A.B. Ackerman Sentinel node biopsy has no benefit for patients whose primary cutaneous melanoma has metastasized to a lymph node and therefore should be abandoned now Br J Dermatol 151 2004 298 307
4. D.B. Pharis, and J.A. Zitelli The management of regional lymph nodes in cancer Br J Dermatol 149 2003 919 925
5. B.M. Coldiron Sentinel node biopsy: who needs it? Int J Dermatol 39 2000 807 811
6. Houghton AN, Coit DG, Chu D, Daud A, Dilawari RA, Gollob JA, et al. National Comprehensive Cancer Network clinical practice guidelines in oncology. V-1.205. Available at: URL: http://www.nccn.org/professionals/physician_gls/ default.asp. Accessed June 24, 2005.
7. Morton DL. Interim results of the multicenter selective lymphadenectomy trial (MSLT-I) in clinical stage I melanoma. Presented at the American Society of Clinical Oncology, May 14, 2005, Orlando, Fla. Available at: URL: http://www.asco.org/ac/1,1003,_12-002511-00_18-0034-00_19-003013-00_21-009,00. asp. Accessed May 24, 2005.
8. D.L. Morton, D.R. Wen, J.H. Wong, J.S. Economou, L.A. Cagle, and F.K. Storm Technical details of intraoperative lymphatic mapping for early stage melanoma Arch Surg 127 1992 392 399
9. H.J. Fee, D.S. Robinson, W.F. Sample, L.S. Graham, E.C. Holmes, and D.L. Morton The determination of lymph shed by colloidal gold scanning in patients with malignant melanoma: a preliminary study Surgery 84 1978 626 632
10. S.D. Nathanson Insights into the mechanisms of lymph node metastasis Cancer 98 2003 413 423
11. K. Fife, and J.F. Thompson Lymph-node metastases in patients with melanoma: what is the optimum management? Lancet Oncol 2 2001 614 621
12. C. Chao, S.L. Wong, M.J. Edwards, M.I. Ross, D.S. Reintgen, and R.D. Noyes Sentinel lymph node biopsy for head and neck melanomas Ann Surg Oncol 10 2003 21 26
13. K.M. McMasters, R.D. Noyes, D.S. Reintgen, J.S. Goydos, P.D. Beitsch, and B.S. Davidson Lessons learned from the sunbelt melanoma trial J Surg Oncol 86 2004 212 223
14. J.E. Gershenwald, W. Thompson, P.F. Mansfield, J.E. Lee, M.I. Colome, and C.H. Tseng Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients J Clin Oncol 17 1999 976 983
15. J.E. Gershenwald, C.H. Tseng, W. Thompson, P.F. Mansfield, J.E. Lee, and M. Bouvet Improved sentinel lymph node localization in patients with primary melanoma with the use of radiolabeled colloid Surgery 124 1998 203 210
16. J.E. Gershenwald, M.I. Colome, J.E. Lee, P.F. Mansfield, C. Tseng, and J.J. Lee Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma J Clin Oncol 16 1998 2253 2260
17. D.L. Morton, D.S. Hoon, A.J. Cochran, R.R. Turner, R. Essner, and H. Takeuchi Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases Ann Surg 238 2003 538 549
18. R.J. Vuylsteke, P.A. van Leeuwen, M.G. Statius Muller, H.A. Gietema, D.R. Kragt, and S. Meijer Clinical outcome of stage I/II melanoma patients after selective sentinel lymph node dissection: long-term follow-up results J Clin Oncol 21 2003 1057 1065
19. D.N. Krag, S.J. Meijer, and D.L. Weaver Minimal-access surgery for staging of malignant melanoma Arch Surg 130 1995 654 660
20. C.V. Godellas, C.G. Berman, and G. Lyman The identification and mapping of melanoma regional nodal metastases: minimally invasive surgery for the diagnosis of nodal metastases Am Surg 61 1995 97 101
21. J.F. Thompson The Sydney melanoma unit experience of sentinel lymphadenectomy for melanoma Ann Surg Oncol 8 Suppl 2001 44S 47S
22. R. Pijpers, P.J. Borgstein, S. Meijer, O.S. Hoekstra, L.H. van Hattum, and G.J. Teule Sentinel node biopsy in melanoma patients: dynamic lymphoscintigraphy followed by intraoperative gamma probe and vital dye guidance World J Surg 21 1997 788 792
23. M.I. Ross, D.S. Reintgen, and C.M. Balch Selective lymphadenectomy: emerging role for lymphatic mapping and sentinel node biopsy in the management of early stage melanoma Semin Surg Oncol 9 1993 219 223
24. D.L. Morton, J.F. Thompson, R. Essner, R. Elashoff, S.L. Stern, and O.E. Nieweg Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial Ann Surg 230 1999 453 463
25. J.J. Albertini, C.W. Cruse, D. Rapaport, K. Wells, M.I. Ross, and R. DeConti Intraoperative radio-lymph-scintigraphy improves sentinel lymph node identification for patients with melanoma Ann Surg 223 1996 217 224
26. S.P. Harlow, D.N. Krag, T. Ashikaga, D.L. Weaver, S.J. Meijer, and B.W. Loggie Gamma probe guided biopsy of the sentinel node in malignant melanoma: a multicentre study Melanoma Res 11 2001 45 55
27. M.E. Robert, D.R. Wen, and A.J. Cochran Pathological evaluation of the regional lymph nodes in malignant melanoma Semin Diagn Pathol 10 1993 102 115
28. A.J. Cochran, D.R. Wen, and D.L. Morton Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma: an immunohistological study Am J Surg Pathol 12 1988 612 618
29. J.D. Wagner, J. Ranieri, D.Z. Evdokimow, T. Logan, T.Y. Chuang, and C.S. Johnson Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma Plast Reconstr Surg 112 2003 486 497
30. S.P. Leong, M.C. Thelmo, R.P. Kim, R. Gokhale, J.Y. Rhee, and T.A. Achtem Delayed harvesting of sentinel lymph nodes after previous wide local excision of extremity melanoma Ann Surg Oncol 10 2003 196 200
31. P.R. Kelemen, R. Essner, L.J. Foshag, and D.L. Morton Lymphatic mapping and sentinel lymphadenectomy after wide local excision of primary melanoma J Am Coll Surg 189 1999 247 252
32. D.J. Karimipour, L. Lowe, L. Su, T. Hamilton, V. Sondak, and T.M. Johnson Standard immunostains for melanoma in sentinel lymph node specimens: which ones are most useful? J Am Acad Dermatol 50 2004 759 764
33. K. Spanknebel, D.G. Coit, S.C. Bieligk, M. Gonen, J. Rosai, and D.S. Klimstra Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis Am J Surg Pathol 29 2005 305 317
34. H.A. Gietema, R.J. Vuylsteke, I.A. de Jonge, P.A. van Leeuwen, B.G. Molenkamp, and J.R. van der Sijp Sentinel lymph node investigation in melanoma: detailed analysis of the yield from step sectioning and immunohistochemistry J Clin Pathol 57 2004 618 620
35. U.S. Kammula, R. Ghossein, S. Bhattacharya, and D.G. Coit Serial follow-up and the prognostic significance of reverse transcriptase-polymerase chain reaction-staged sentinel lymph nodes from melanoma patients J Clin Oncol 22 2004 3989 3996
36. J.F. Thompson, R.F. Uren, H.M. Shaw, W.H. McCarthy, M.J. Quinn, and C.J. O'Brien Location of sentinel lymph nodes in patients with cutaneous melanoma: new insights into lymphatic anatomy J Am Coll Surg 189 1999 195 204
37. J.F. Thompson, and R.F. Uren Teaching points on lymphatic mapping for melanoma from the Sydney melanoma unit Semin Oncol 31 2004 349 356
38. K.M. McMasters, C. Chao, S.L. Wong, W.R. Wrightson, M.I. Ross, and D.S. Reintgen Interval sentinel lymph nodes in melanoma Arch Surg 137 2002 543 547
39. R.F. Uren, R. Howman-Giles, J.F. Thompson, W.H. McCarthy, M.J. Quinn, and J.M. Roberts Interval nodes: the forgotten sentinel nodes in patients with melanoma Arch Surg 135 2000 1168 1172
40. C.M. Balch, S.J. Soong, J.E. Gershenwald, J.F. Thompson, D.S. Reintgen, and N. Cascinelli Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system J Clin Oncol 19 2001 3622 3634
41. C.M. Balch, A.C. Buzaid, S.J. Soong, M.B. Atkins, N. Cascinelli, and D.G. Coit Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma J Clin Oncol 19 2001 3635 3648
42. E.P. Miranda, M. Gertner, J. Wall, E. Grace, M. Kashani-Sabet, and R. Allen Routine imaging of asymptomatic melanoma patients with metastasis to sentinel lymph nodes rarely identifies systemic disease Arch Surg 139 2004 831 836
43. C.R. Ferrone, K.S. Panageas, K. Busam, M.S. Brady, and D.G. Coit Multivariate prognostic model for patients with thick cutaneous melanoma: importance of sentinel lymph node status Ann Surg Oncol 9 2002 637 645
44. J.E. Gershenwald, P.F. Mansfield, J.E. Lee, and M.I. Ross Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (≥4 mm) primary melanoma Ann Surg Oncol 7 2000 160 165
45. J.F. Thompson, and H.M. Shaw The prognosis of patients with thick primary melanomas: is regional lymph node status relevant, and does removing positive regional nodes influence outcome? Ann Surg Oncol 9 2002 719 722
46. H. Tsao, M. Feldman, J.E. Fullerton, A.J. Sober, D. Rosenthal, and W. Goggins Early detection of asymptomatic pulmonary melanoma metastases by routine chest radiographs is not associated with improved survival Arch Dermatol 140 2004 67 70
47. J. Hafner, M.H. Schmid, W. Kempf, G. Burg, W. Kunzi, and C. Meuli-Simmen Baseline staging in cutaneous malignant melanoma Br J Dermatol 150 2004 677 686
48. T.S. Wang, T.M. Johnson, P.N. Cascade, B.G. Redman, V.K. Sondak, and J.L. Schwartz Evaluation of staging chest radiographs and serum lactate dehydrogenase for localized melanoma J Am Acad Dermatol 51 2004 399 405
49. R.R. White, W.E. Stanley, J.L. Johnson, D.S. Tyler, and H.F. Seigler Long-term survival in 2,505 patients with melanoma with regional lymph node metastasis Ann Surg 235 2002 879 887
50. T.M. Pawlik, M.I. Ross, and J.E. Gershenwald Lymphatic mapping in the molecular era Ann Surg Oncol 11 2004 362 374
51. T. Meyer, S. Merkel, J. Gohl, and W. Hohenberger Lymph node dissection for clinically evident lymph node metastases of malignant melanoma Eur J Surg Oncol 28 2002 424 430
52. J.H.F. Shaw, and E.M. Rumball Complications and local recurrence following lymphadenectomy Br J Surg 77 1990 7604
53. C.P. Karakousis, W. Goumas, U. Rao, and D.L. Driscoll Axillary node dissection in malignant melanoma Am J Surg 162 1991 2027
54. J.E. Gershenwald, R.S. Berman, G. Porter, P.F. Mansfield, J.E. Lee, and M.I. Ross Regional nodal basin control is not compromised by previous sentinel lymph node biopsy in patients with melanoma Ann Surg Oncol 7 2000 226 231
55. T.R. Fincher, T.M. McCarty, T.L. Fisher, J.T. Preskitt, Z.H. Lieberman, and J.F. Stephens Patterns of recurrence after sentinel lymph node biopsy for cutaneous melanoma Am J Surg 186 2003 675 681
56. B.M. Clary, M.S. Brady, J.J. Lewis, and D.G. Coit Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence Ann Surg 233 2001 250 258
57. M.G. Statius Muller, P.A. van Leeuwen, P.J. van Diest, R. Pijpers, R.J. Nijveldt, and R.J. Vuylsteke Pattern and incidence of first site recurrences following sentinel node procedure in melanoma patients World J Surg 26 2002 1405 1411
58. J.W. Serpell, P.W. Carne, and M. Bailey Radical lymph node dissection for melanoma ANZ J Surg 73 2003 294 299
59. R. Blumenthal, A. Banic, C.U. Brand, H.B. Ris, and D. Lardinois Morbidity and outcome after sentinel lymph node dissection in patients with early-stage malignant cutaneous melanoma Swiss Surg 8 2002 209 214
60. R.J. Lee, J.F. Gibbs, G.M. Proulx, D.R. Kollmorgen, C. Jia, and W.G. Kraybill Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy Int J Radiat Oncol Biol Phys 46 2000 467 474
61. I. Pidhorecky, R.J. Lee, G. Proulx, D.R. Kollmorgen, C. Jia, and D.L. Driscoll Risk factors for nodal recurrence after lymphadenectomy for melanoma Ann Surg Oncol 8 2001 109 115
62. C.L. Slingluff Jr., K.R. Stidham, W.M. Ricci, W.E. Stanley, and H.F. Seigler Surgical management of regional lymph nodes in patients with melanoma: experience with 4682 patients Ann Surg 219 1994 120 130
63. A. Calabro, S.E. Singletary, and C.M. Balch Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases Arch Surg 124 1989 1051 1055
64. M.T. Ballo, E.A. Strom, G.K. Zagars, A.Y. Bedikian, V.G. Prieto, and P.F. Mansfield Adjuvant irradiation for axillary metastases from malignant melanoma Int J Radiat Oncol Biol Phys 52 2002 964 972
65. E.A. Strom, and M.I. Ross Adjuvant radiation therapy after axillary lymphadenectomy for metastatic melanoma: toxicity and local control Ann Surg Oncol 2 1995 445 449
66. L. Kretschmer, R. Hilgers, M. Mohrle, B.R. Balda, H. Breuninger, and B. Konz Patients with lymphatic metastasis of cutaneous malignant melanoma benefit from sentinel lymphonodectomy and early excision of their nodal disease Eur J Cancer 40 2004 212 218
67. L. Kretschmer, I. Beckmann, K.M. Thoms, H. Haenssle, H.P. Bertsch, and C.H. Neumann Sentinel lymphonodectomy does not increase the risk of loco-regional cutaneous metastases of malignant melanomas Eur J Cancer 41 2005 531 538
68. L. Kretschmer, K.P. Preusser, W.C. Marsch, and C. Neumann Prognostic factors of overall survival in patients with delayed lymph node dissection for cutaneous malignant melanoma Melanoma Res 10 2000 483 489
69. C.M. Balch, S. Soong, M.I. Ross, M.M. Urist, C.P. Karakousis, and W.J. Temple Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm): intergroup melanoma surgical trial Ann Surg Oncol 7 2000 87 97
70. N. Cascinelli, A. Morabito, M. Santinami, R.M. MacKie, and F. Belli Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomized trial; WHO melanoma programme Lancet 351 1998 793 796
71. C.M. Balch, S.J. Soong, A.A. Bartolucci, M.M. Urist, C.P. Karakousis, and T.J. Smith Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger Ann Surg 224 1996 255 263
72. C.M. Balch, A.C. Buzaid, M.B. Atkins, N. Cascinelli, D.G. Coit, and I.D. Fleming A new American Joint Committee on Cancer staging system for cutaneous melanoma Cancer 88 2000 1484 1491
73. U. Veronesi, J. Adamus, D.C. Bandiera, I.O. Brennhovd, E. Caceres, and N. Cascinelli Inefficacy of immediate node dissection in stage 1 melanoma of the limbs N Engl J Med 297 1977 627 630
74. A.J. Cochran, D.L. Morton, S. Stern, A.M. Lana, R. Essner, and D.R. Wen Sentinel lymph nodes show profound downregulation of antigen-presenting cells of the paracortex: implications for tumor biology and treatment Mod Pathol 14 2001 604 608
75. J.H. Lee, H. Torisu-Itakara, A.J. Cochran, A. Kadison, Y. Huynh, and D.L. Morton Quantitative analysis of melanoma-induced cytokine-mediated immunosuppression in melanoma sentinel nodes Clin Cancer Res 11 2005 107 112
76. A. Zippelius, P. Batard, V. Rubio-Godoy, G. Bioley, D. Lienard, and F. Lejeune Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance Cancer Res 64 2004 2865 2873
77. R. Botella-Estrada, F. Dasi, D. Ramos, E. Nagore, M.J. Herrero, and J. Gimenez Cytokine expression and dendritic cell density in melanoma sentinel nodes Melanoma Res 15 2005 99 106
78. D.S. Hoon, R.J. Bowker, and A.J. Cochran Suppressor cell activity in melanoma-draining lymph nodes Cancer Res 47 1987 1529 1533
79. A.J. Cochran, E. Pihl, D.R. Wen, D.S. Hoon, and E.L. Korn Zoned immune suppression of lymph nodes draining malignant melanoma: histologic and immunohistologic studies J Natl Cancer Inst 78 1987 399 405
80. D.S. Hoon, E.L. Korn, and A.J. Cochran Variations in functional immunocompetence of individual tumor-draining lymph nodes in humans Cancer Res 47 1987 1740 1744
81. A.M. Lana, D.R. Wen, and A.J. Cochran The morphology, immunophenotype and distribution of paracortical dendritic leucocytes in lymph nodes regional to cutaneous melanoma Melanoma Res 11 2001 401 410
82. G. Frumento, R. Rotondo, M. Tonetti, G. Damonte, U. Benatti, and G.B. Ferrara Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase J Exp Med 196 2002 459 468
83. D.H. Munn, M. Zhou, J.T. Attwood, I. Bondarev, S.J. Conway, and B. Marshall Prevention of allogeneic fetal rejection by tryptophan catabolism Science 281 1998 1191 1193
84. R.J. Vuylsteke, B.G. Molenkamp, H.A. Gietema, P.A. van Leeuwen, P.G. Wijnands, and W. Vos Local administration of granulocyte/macrophage colony-stimulating factor increases the number and activation state of dendritic cells in the sentinel lymph node of early-stage melanoma Cancer Res 64 2004 8456 8460
85. M.I. Ross The case for elective lymphadenectomy Surg Oncol Clin North Am 1 1992 205
86. S.H. Estourgie, O.E. Nieweg, and B.B. Kroon High incidence of in-transit metastases after sentinel node biopsy in patients with melanoma Br J Surg 91 2004 1370 1371
87. J.M. Thomas, and M.A. Clark Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma Eur J Surg Oncol 30 2004 686 691
88. T.M. Pawlik, M.I. Ross, M.M. Johnson, C.W. Schacherer, D.M. McClain, and P.F. Mansfield Predictors and natural history of in-transit melanoma after sentinel lymphadenectomy Ann Surg Oncol 12 2005 587 596
89. S.J. Pacella, L. Lowe, C. Bradford, B.C. Marcus, T. Johnson, and R. Rees The utility of sentinel lymph node biopsy in head and neck melanoma in the pediatric population Plast Reconstr Surg 112 2003 1257 1265
90. C.E. Schmalbach, B. Nussenbaum, R.S. Rees, J. Schwartz, T.M. Johnson, and C.R. Bradford Reliability of sentinel lymph node mapping with biopsy for head and neck cutaneous melanoma Arch Otolaryngol Head Neck Surg 129 2003 61 65
91. M.E. Wechter, S.B. Gruber, H.K. Haefner, L. Lowe, J.L. Schwartz, and K.R. Reynolds Vulvar melanoma: a report of 20 cases and review of the literature J Am Acad Dermatol 50 2004 554 562
92. J.L. Schwartz, E.L. Mozurkewich, and T.M. Johnson Current management of patients with melanoma who are pregnant, want to get pregnant, or do not want to get pregnant Cancer 97 2003 2130 2133
93. N. Nijhawan, M.I. Ross, R. Diba, M.A. Ahmadi, and B. Esmaeli Experience with sentinel lymph node biopsy for eyelid and conjunctival malignancies at a cancer center Ophthal Plast Reconstr Surg 21 2005 10
94. H.L. Neville, R.J. Andrassy, K.P. Lally, C. Corpron, and M.I. Ross Lymphatic mapping with sentinel node biopsy in pediatric patients J Pediatr Surg 35 2000 961 964
95. B. Esmaeli Sentinel node biopsy as a tool for accurate staging of eyelid and conjunctival malignancies Curr Opin Ophthalmol 13 2002 317 323
96. J.H. Lee, R. Essner, H. Torisu-Itakura, L. Wanek, H. Wang, and D.L. Morton Factors predictive of tumor-positive nonsentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma J Clin Oncol 22 2004 3677 3684
97. R.J. Vuylsteke, P.J. Borgstein, P.A. van Leeuwen, H.A. Gietema, B.G. Molenkamp, and M.G. Muller Sentinel lymph node tumor load: an independent predictor of additional lymph node involvement and survival in melanoma Ann Surg Oncol 12 2005 440 448
98. G.I. Salti, and T.K. Das Gupta Predicting residual lymph node basin disease in melanoma patients with sentinel lymph node metastases Am J Surg 186 2003 98 101
99. M.S. Sabel, K. Griffith, V.K. Sondak, L. Lowe, J.L. Schwartz, and V.M. Cimmino Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma J Am Coll Surg 201 2005 37 47
100. M.E. Reeves, R. Delgado, K.J. Busam, M.S. Brady, and D.G. Coit Prediction of nonsentinel lymph node status in melanoma Ann Surg Oncol 10 2003 27 31
101. K.M. McMasters, S.L. Wong, M.J. Edwards, C. Chao, M.I. Ross, and R.D. Noyes Frequency of nonsentinel lymph node metastasis in melanoma Ann Surg Oncol 9 2002 137 141
102. N. Elias, K.K. Tanabe, A.J. Sober, M.A. Gadd, M.C. Mihm, and B. Goodspeed Is completion lymphadenectomy after a positive sentinel lymph node biopsy for cutaneous melanoma always necessary? Arch Surg 139 2004 400 404
103. A.J. Cochran, D.R. Wen, R.R. Huang, H.J. Wang, R. Elashoff, and D.L. Morton Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node Mod Pathol 17 2004 747 755
104. D.J. Dewar, B. Newell, M.A. Green, A.P. Topping, B.W. Powell, and M.G. Cook The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement J Clin Oncol 22 2004 3345 3349
105. M.S. Sabel, and V.K. Sondak Pros and cons of adjuvant interferon in the treatment of melanoma Oncologist 8 2003 451 458
106. C. Haqq, M. Nosrati, D. Sudilovsky, J. Crothers, D. Khodabakhsh, and B.L. Pulliam The gene expression signatures of melanoma progression Proc Natl Acad Sci U S A 102 2005 6092 6097
107. M. Bittner, P. Meltzer, Y. Chen, Y. Jiang, E. Seftor, and M. Hendrix Molecular classification of cutaneous malignant melanoma by gene expression profiling Nature 406 2000 536 540
108. R. Pardal, M.F. Clarke, and S.J. Morrison Applying the principles of stem-cell biology to cancer Nat Rev Cancer 3 2003 895 902
109. J.A. Carlson, J.S. Ross, A. Slominski, G. Linette, J. Mysliborski, and J. Hill Molecular diagnostics in melanoma J Am Acad Dermatol 52 2005 743 775